Rapid and Accurate Diagnosis of the Respiratory Disease Pertussis on a Point-of-Care Biochip

Background: Pertussis is a highly contagious respiratory disease caused by the bacterium Bordetella pertussis (B. pertussis). The infection is difficult to diagnose especially in underserved or resource-limited areas. We developed a low-cost and instrument-free diagnostic method for rapid and accura...

Full description

Bibliographic Details
Main Authors: Maowei Dou, Natalie Macias, Feng Shen, Jennifer Dien Bard, Delfina C. Domínguez, XiuJun Li
Format: Article
Language:English
Published: Elsevier 2019-02-01
Series:EClinicalMedicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537019300343
id doaj-3c6469cdeda7452bb97ecd0ccfef4728
record_format Article
spelling doaj-3c6469cdeda7452bb97ecd0ccfef47282020-11-24T20:45:02ZengElsevierEClinicalMedicine2589-53702019-02-0187277Rapid and Accurate Diagnosis of the Respiratory Disease Pertussis on a Point-of-Care BiochipMaowei Dou0Natalie Macias1Feng Shen2Jennifer Dien Bard3Delfina C. Domínguez4XiuJun Li5Department of Chemistry and Biochemistry, University of Texas at El Paso, El Paso, TX, USADepartment of Chemistry and Biochemistry, University of Texas at El Paso, El Paso, TX, USADepartment of Chemistry and Biochemistry, University of Texas at El Paso, El Paso, TX, USADepartment of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, California, USA; Keck School of Medicine, University of Southern California, Los Angeles, CA, USAClinical Laboratory Science, Department of Public Health Sciences, University of Texas at El Paso, 500 West University Ave, El Paso, TX 79968, USA; Corresponding authors.Department of Chemistry and Biochemistry, Biomedical Engineering, Border Biomedical Research Center, Environmental Science and Engineering, University of Texas at El Paso, 500 West University Ave, El Paso, TX 79968, USA; Corresponding authors.Background: Pertussis is a highly contagious respiratory disease caused by the bacterium Bordetella pertussis (B. pertussis). The infection is difficult to diagnose especially in underserved or resource-limited areas. We developed a low-cost and instrument-free diagnostic method for rapid and accurate detection of B. pertussis on a point-of-care (POC) testing device. Methods: We developed a paper/polymer hybrid microfluidic biochip integrated with loop-mediated isothermal amplification (LAMP) method for the rapid and accurate detection of B. pertussis. This microfluidic approach was validated by testing 100 de-identified remnant clinical nasopharyngeal swabs and aspirates, which were confirmed to be either positive or negative for B. pertussis by a validated real-time PCR assay at the Children's Hospital Los Angeles. Findings: The instrument-free detection results could be successfully read by the naked eye within 45 min with a limit of detection (LOD) of 5 DNA copies per well. Our optimized bacterial lysis protocol allowed the direct testing of clinical samples without any complicated sample processing/preparation (i.e. DNA extraction) or the use of any equipment (e.g. centrifuges). The validation of the microfluidic approach was accomplished by testing 100 clinical samples. High sensitivity (100%) and specificity (96%) with respect to real-time PCR were achieved. Interpretation: This microfluidic biochip shows great potential for point-of-care disease diagnosis in various venues including schools and physician's offices, especially in low-resource settings in developing nations. Funding: NIH/NIAID under award number R21AI107415, NIH RCMI Pilot Grant, the Philadelphia Foundation, the Medical Center of the Americas Foundation. Keywords: Pertussis diagnosis, Point-of-care detection, Microfluidic biochip, Whooping cough, Loop-mediated isothermal amplification (LAMP)http://www.sciencedirect.com/science/article/pii/S2589537019300343
collection DOAJ
language English
format Article
sources DOAJ
author Maowei Dou
Natalie Macias
Feng Shen
Jennifer Dien Bard
Delfina C. Domínguez
XiuJun Li
spellingShingle Maowei Dou
Natalie Macias
Feng Shen
Jennifer Dien Bard
Delfina C. Domínguez
XiuJun Li
Rapid and Accurate Diagnosis of the Respiratory Disease Pertussis on a Point-of-Care Biochip
EClinicalMedicine
author_facet Maowei Dou
Natalie Macias
Feng Shen
Jennifer Dien Bard
Delfina C. Domínguez
XiuJun Li
author_sort Maowei Dou
title Rapid and Accurate Diagnosis of the Respiratory Disease Pertussis on a Point-of-Care Biochip
title_short Rapid and Accurate Diagnosis of the Respiratory Disease Pertussis on a Point-of-Care Biochip
title_full Rapid and Accurate Diagnosis of the Respiratory Disease Pertussis on a Point-of-Care Biochip
title_fullStr Rapid and Accurate Diagnosis of the Respiratory Disease Pertussis on a Point-of-Care Biochip
title_full_unstemmed Rapid and Accurate Diagnosis of the Respiratory Disease Pertussis on a Point-of-Care Biochip
title_sort rapid and accurate diagnosis of the respiratory disease pertussis on a point-of-care biochip
publisher Elsevier
series EClinicalMedicine
issn 2589-5370
publishDate 2019-02-01
description Background: Pertussis is a highly contagious respiratory disease caused by the bacterium Bordetella pertussis (B. pertussis). The infection is difficult to diagnose especially in underserved or resource-limited areas. We developed a low-cost and instrument-free diagnostic method for rapid and accurate detection of B. pertussis on a point-of-care (POC) testing device. Methods: We developed a paper/polymer hybrid microfluidic biochip integrated with loop-mediated isothermal amplification (LAMP) method for the rapid and accurate detection of B. pertussis. This microfluidic approach was validated by testing 100 de-identified remnant clinical nasopharyngeal swabs and aspirates, which were confirmed to be either positive or negative for B. pertussis by a validated real-time PCR assay at the Children's Hospital Los Angeles. Findings: The instrument-free detection results could be successfully read by the naked eye within 45 min with a limit of detection (LOD) of 5 DNA copies per well. Our optimized bacterial lysis protocol allowed the direct testing of clinical samples without any complicated sample processing/preparation (i.e. DNA extraction) or the use of any equipment (e.g. centrifuges). The validation of the microfluidic approach was accomplished by testing 100 clinical samples. High sensitivity (100%) and specificity (96%) with respect to real-time PCR were achieved. Interpretation: This microfluidic biochip shows great potential for point-of-care disease diagnosis in various venues including schools and physician's offices, especially in low-resource settings in developing nations. Funding: NIH/NIAID under award number R21AI107415, NIH RCMI Pilot Grant, the Philadelphia Foundation, the Medical Center of the Americas Foundation. Keywords: Pertussis diagnosis, Point-of-care detection, Microfluidic biochip, Whooping cough, Loop-mediated isothermal amplification (LAMP)
url http://www.sciencedirect.com/science/article/pii/S2589537019300343
work_keys_str_mv AT maoweidou rapidandaccuratediagnosisoftherespiratorydiseasepertussisonapointofcarebiochip
AT nataliemacias rapidandaccuratediagnosisoftherespiratorydiseasepertussisonapointofcarebiochip
AT fengshen rapidandaccuratediagnosisoftherespiratorydiseasepertussisonapointofcarebiochip
AT jenniferdienbard rapidandaccuratediagnosisoftherespiratorydiseasepertussisonapointofcarebiochip
AT delfinacdominguez rapidandaccuratediagnosisoftherespiratorydiseasepertussisonapointofcarebiochip
AT xiujunli rapidandaccuratediagnosisoftherespiratorydiseasepertussisonapointofcarebiochip
_version_ 1716815793374625792